Listed drug analysis report! 81 Medicare drugs, 14 exclusive varieties, 47 listed licensed varieties.

Guide: Exclusive! August 2020 Drug Analysis Report.
the total number of new approvals issued by the Drug Administration in August was 141.
14 new exclusive varieties were approved in August.
138 new domestic drug approvals in August.
, according to the latest statistics of the enterprise edition of Pharmaceutical Intelligence Data, 141 new approvals were issued in August 2020.
2020 New Approvals 138 domestically produced drugs and 3 imported medicines were approved in August 2020.
below and look at the detailed analysis of the new approvals.
, the drug type situation in August, the Drug Administration added 83 chemical drug approvals, of which 2 approvals for imported drugs, 1 biological products approval and 57 Chinese medicine approvals.
Figure II January-August 2020 Drug Types Of the Drug Administration Figure III August 2020 Drug Types of the Drug Administration II, Dosage Forms August the Drug Administration's new approval of the first three dosage forms: tablets 50 approvals, 18 approvals of granules, 15 approvals of pills (see figure below).
Figure IV In August 2020, the Drug Administration of the various dosage forms iii, the medical insurance category in August of the new approval of 26 approvals belong to the 2019 new version of the national medical insurance directory of Class A drugs, 55 approvals belong to the 2019 new version of the National Health Insurance Directory of Class B drugs, two of the Class B drugs are imported drugs.
Figure V January-August 2020 Drug Administration of the various types of medical insurance situation Figure 6 August 2020 of the Drug Administration of the various types of medical insurance situation IV, the number of approvals in each province in August the registration address of new approval production enterprises for Chongqing ranked first, there are 53.
7 August 2020 the provinces have the number of approvals five, exclusive situation with the same variety of exclusive 14 approvals, see Table 1 for details.
Figure 8 The number of exclusive categories of the same variety in August 2020 Table 1 Exclusive drug data of the same variety as of August 31, 2020 there are 35 approvals of the same product regulations (the same product regulations exclusively contain exclusive varieties), see Table 2 for details.
Chart 9 In August 2020, the number of exclusive categories of the same product regulations Table 2 In August 2020, the exclusive drug data of the same product regulations ended on August 31, 2020, the listed license holder varieties 8 In the month, 47 new varieties of listed licensees were added, of which the production enterprises of the two varieties of "zusalated salamine alcohol hydrochloric acid atomized inhalation solution" and "tansorosin slow release capsule hydrochloric acid" were inconsistent with the listed license holders, and the rest were consistent.
details can be found in table 3.
3, 2020 listing license holders variety data as of August 31, 2020 Data source: Pharmaceutical Intelligence China listed drug database.